本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Editas Medicine, Inc.

2.70
+0.05001.89%
盤後2.700.00000.00%19:30 EDT
成交量:246.37萬
成交額:658.79萬
市值:4.13億
市盈率:-3.69
高:2.72
開:2.68
低:2.62
收:2.65
52周最高:4.54
52周最低:1.66
股本:1.53億
流通股本:1.15億
量比:1.17
換手率:2.14%
股息:- -
股息率:- -
每股收益(TTM):-0.7307
每股收益(LYR):-1.8036
淨資產收益率:-118.82%
總資產收益率:-23.29%
市淨率:3.92
市盈率(LYR):-1.50

資料載入中...

2026/09/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/04

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/04

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/02

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report